Here are the biggest calls on Wall Street on Thursday:
Raymond James upgrades Equinix to strong buy from outperform
Raymond James upgraded the communication services company following earnings.
“We are upgrading shares of Equinix (EQIX) to Strong Buy from Market Perform following 1Q26 results. We believe Equinix is firmly back in the driver seat after last year’s adjustments and is benefiting from AI-based demand and its unique assets.”
Deutsche Bank upgrades SiteOne Landscape to buy from hold
Deutsche said in its upgrade of SiteOne that it’s getting more constructive on the landscape company following earnings.
“With the stock set up for a guidance beat, we believe this low valuation is an attractive entry point and we are upgrading the stock to a Buy. Our price target of $160, which uses an EV/EBITDA multiple of 16x, is in-line with its average over the past 4 years and implies upside of 32%.”
Roth Capital initiates Mistras as buy
Roth says the asset protection solutions company is firing on all cylinders.
“We initiate MISTRAS with a Buy and $22 target. MISTRAS has significantly improved its operating efficiency, driving margin expansion, profitability and conversion to free cash flow.”
Bank of America reiterates Nvidia as buy
The firm says it’s standing by the tech giant.
“Our $300 PO is based on 28x CY27E PE ex cash, within NVDA’s historical 25x-56x forward year PE range, which we believe is justified by NVDA’s leading share in fast- growing AI compute/networking markets, offset by lumpiness in global AI projects, cyclical gaming market, and concerns around access to power.”
Oppenheimer initiates Palantir as outperform
Oppenheimer says Palantir is firing on all cylinders.
“We are initiating coverage of AI application software and data analytics leader Palantir (PLTR) with an Outperform rating and a $200 PT.”
Baird upgrades Blackbaud to outperform from neutral
Baird says buy the weakness following the software company’s earnings.
“Following BLKB’s Q1′26 result, we are upgrading shares to Outperform. Q1 was a solid quarter featuring a beat on top and bottom lines. Importantly, retention remains steady. We are encouraged by the focus on new logos as well as the opportunity to cross-sell within the installed base.”
JPMorgan upgrades Teradyne to overweight from neutral
JPMorgan says investors should buy the dip following earnings.
“We are upgrading Teradyne to Overweight following a post earnings pullback in the stock driven by lumpiness in customer purchasing of test equipment impacting near-term visibility...”
JPMorgan downgrades Meta to neutral from overweight
JPMorgan downgraded the stock due to rising competition.
“While we’re encouraged by META’s +33% Y/Y revenue growth which has been supported by AI-driven ad stack optimizations, accelerating impression growth, & engagement gains, we believe full-stack AI competition is intensifying and Meta has a more challenging path to returns on heavy AI capex beyond advertising.”
Read more.
Bank of America upgrades Nutrien to buy from neutral
The firm says it sees a “bullish backdrop” for Nutrien shares.
“We upgrade Nutrien to Buy from Neutral as a best-in-class operator in an agriculture market which looks increasingly bound for a more sustained bullish backdrop.”
Bank of America upgrades AbbVie to buy from neutral
Bank of America says competition fears are overdone.
“We rate ABBV a Buy: 1) its premium multiple looks warranted given growth near the top of the peer group and limited identifiable portfolio headwinds in the next 7 years, 2) we see strong and durable growth prospect in core immunology brands despite increasing competitions, and 3) room for upside tied to pipeline efforts.”
Morgan Stanley reiterates Microsoft as overweight
Morgan Stanley says it’s sticking with the stock following earnings on Wednesday.
“Agentic computing fundamentally expands the TAM, with usage based pricing expanding the monetization of that TAM, while Microsoft uses AI to improve the margin profile. While investors may bristle at the Capex levels necessary to service this TAM, we see it as a wise investment. Remain OW.”
Bank of America reiterates Amazon as buy
Bank of America raised its price target to $310 per share from $298 following earnings.
“Amazon is an eCommerce and cloud computing market share leader that operates a leading fulfilment network and data center footprint. Given strong assets and customer focus, we think Amazon is well positioned to capitalize on the global growth of eCommerce and enterprise demand for AI capacity.”
JPMorgan reiterates Alphabet as overweight
The firm raised its price target to $460 per share from $395 following earnings on Wednesday.
“We believe Google is generating clear, measurable returns on its AI investments as Cloud backlog nearly doubled sequentially to $462B with AI Solutions now the primary growth driver, Search queries hit an all-time high as AI experiences expand the addressable market, and paid subscriptions reached 350M driven by strong demand for consumer AI plans.”
Wells Fargo reiterates Meta as overweight
Wells says shares of Meta have plenty more room to run following earnings.
“Robust ad growth despite some macro headwinds related to Middle East conflict, but product catalysts seemingly pushed to 2H delaying catalyst path. Not yet time to get aggressive here w/ OpEx growth ramping and Street ’27 CapEx ests moving higher.”
JPMorgan reiterates Qualcomm as neutral
JPMorgan says the company needs further execution following earnings.
“Qualcomm delivered a modest earnings beat in F2Q26, but the headwinds in the smartphone industry drove F3Q guide to track below consensus, led in part by expectations for another quarter of the company under-shipping relative to end customer demand as Chinese OEMs continue to digest inventory.”
Morgan Stanley reiterates Carvana as overweight
The firm raised its price target to $510 per share from $450 following earnings.
“CVNA delivered strong profitable growth with a clean beat and momentum for FY26.
Guggenheim upgrades Everus Construction Group to buy from neutral
Guggenheim says there is margin improvement for the infrastructure service company.
“We are upgrading our rating from Neutral to Buy and establishing a$160 price target ahead of ECG’s 1Q26 earnings report.”
Comments